Jiangsu Hualv Biological Technology Co.Ltd. (300970) — Free Cash Flow Generation Index
Jiangsu Hualv Biological Technology Co.Ltd. (300970) has a Free Cash Flow Generation Index of 0.64x as of December 2025. Free cash flow of CN¥222.19 Million represents 1% of operating cash flow (CN¥345.31 Million). Read Jiangsu Hualv Biological Technology Co.L (300970) financial obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jiangsu Hualv Biological Technology Co.Ltd. Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for Jiangsu Hualv Biological Technology Co.Ltd. across 7 annual periods. Explore Jiangsu Hualv Biological Technology Co.L capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Jiangsu Hualv Biological Technology Co.Ltd. (2019–2025)
Year-by-year Free Cash Flow Generation Index for Jiangsu Hualv Biological Technology Co.Ltd.. For the full company profile including market capitalisation, see 300970 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.64x | CN¥222.19 Million | CN¥345.31 Million | CN¥123.12 Million | ▲ +168.0% |
| 2024 | -0.95x | CN¥-130.42 Million | CN¥137.80 Million | CN¥268.22 Million | ▼ -174.4% |
| 2023 | -0.34x | CN¥-57.48 Million | CN¥166.67 Million | CN¥224.15 Million | ▲ +72.8% |
| 2022 | -1.27x | CN¥-228.07 Million | CN¥179.84 Million | CN¥407.91 Million | ▲ +12.9% |
| 2021 | -1.46x | CN¥-121.01 Million | CN¥83.08 Million | CN¥204.09 Million | ▼ -3667.9% |
| 2020 | 0.04x | CN¥8.13 Million | CN¥199.09 Million | CN¥190.96 Million | ▼ -92.4% |
| 2019 | 0.54x | CN¥115.42 Million | CN¥213.96 Million | CN¥98.54 Million | — |